SCHEMBL1935995

SCHEMBL1935995

CC(C)(C)OC(=O)ON1CCC(N)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
HPGD P15428 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
RECQL P46063 1/20 0.33
EPHX1 P07099 1/20 0.33
USP2 O75604 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CTSK P43235 2/20 0.32
HRH3 Q9Y5N1 1/20 0.32
GNAI3 P08754 1/20 0.32
GNAO1 P09471 1/20 0.32
GNAI1 P63096 1/20 0.32
PREP P48147 1/20 0.31
GPR119 Q8TDV5 2/20 0.31
DGAT1 O75907 1/20 0.31
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16341947 0.91 CHRM1 (0.34) CHRM2CHRM1CHRM3HPGDKDM4E
SCHEMBL4440743 0.90 CTSK (0.33) CHRM2CHRM1CHRM3HPGDKDM4E
SCHEMBL212033 0.84 CHRM2 (0.42) CHRM2CHRM1CHRM3HPGDKDM4E
SCHEMBL27637917 0.83 GNAI3 (0.34) CHRM2CHRM1CHRM3HPGDGNAI3
SCHEMBL373788 0.83 SMN1; SMN2 (0.43) CHRM1HPGDRECQLSMN1; SMN2HRH3
SCHEMBL5258386 0.81 NCF1 (0.40) CHRM2CHRM1CHRM3HPGDKDM4E
SCHEMBL1550155 0.80 HPGD (0.37) CHRM2CHRM1CHRM3HPGDRECQL
SCHEMBL1133757 0.79 NR1H2 (0.43) CHRM2CHRM1CHRM3HPGDKDM4E
SCHEMBL2326335 0.79 EPHX1 (0.40) CHRM2CHRM1CHRM3HPGDMAPT
SCHEMBL4434089 0.79 HPGD (0.39) CHRM2CHRM1CHRM3HPGDEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331506-B1 NOVEL BENZAMIDES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2013-07-03 EP disclosed
EP-2331506-A1 NOVEL BENZAMIDES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2011-06-15 EP disclosed
WO-2010026095-A1 NOVEL BENZAMIDES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-03-11 WO disclosed
EP-1903038-A1 N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators Bayer Schering Pharma Aktiengesellschaft (DE) 2008-03-26 EP disclosed
EP-1903037-A1 1-(hetero)aryl-3-[heteroaryl-piperidin-4yl]-thiourea derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-03-26 EP disclosed
EP-1900731-A1 N-(1-Phthalazin-1-yl-piperidin-4-yl)-amides as EP2-receptor modulators Bayer Schering Pharma Aktiengesellschaft (DE) 2008-03-19 EP disclosed